Integrated digital pathology and transcriptomics identified TGF-β–driven loss of antigen presentation and fibroblast activation as mediators of T-cell exclusion in ovarian tumors, with reduced MHC-I on cancer cells and desmoplastic barriers that hinder infiltration (16–18). This evidence concerns the gene TGFB1 and ovarian neoplasm.